<?xml version="1.0" encoding="UTF-8"?>
<p>Due to the absence of any specified treatment for COVID-19, researchers are still searching for potential therapeutic agents and an effective line of treatment to contain the disease. The implementation of CP therapy against COVID-19 was checked based on its past trials and the successful treatment of several viral-mediated epidemics and pandemics [
 <xref rid="RSOB200174C84" ref-type="bibr">84</xref>]. To date, several studies have reported the efficacy of CP therapy in curing patients with SARS-CoV-2 infection [
 <xref rid="RSOB200174C54" ref-type="bibr">54</xref>,
 <xref rid="RSOB200174C85" ref-type="bibr">85</xref>,
 <xref rid="RSOB200174C86" ref-type="bibr">86</xref>]. 
 <xref rid="RSOB200174TB1" ref-type="table">TableÂ 1</xref> precisely enlists the CP administration in previously encountered CoV diseases, along with COVID-19. 
</p>
